Company Profiles

TVA Medical

Description

Provider of therapies for end-stage renal disease. The company is developing a catheter-based system that allows physicians to create an arterio-venous fistula (joining an artery to a vein) to deliver hemodialysis to patients suffering from kidney failure.

2007

Founded

PRIVATE

Status

11-50

Employees

Series C

Latest Deal Type

$15.3M

Latest Deal Amount

$33.4M

Total Amount Raised

Description

Provider of therapies for end-stage renal disease. The company is developing a catheter-based system that allows physicians to create an arterio-venous fistula (joining an artery to a vein) to deliver hemodialysis to patients suffering from kidney failure.